Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
NSC001 AF267B ,
NGX267,
NI004
Alzheimer's Disease (Phase 1/2) Neurimmune, TorreyPines Therapeutics, Inc. Cholinergic System Small Molecule None